# Phibro Animal Health (PAHC) — Analyst Forecast

PAHC · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/pahc/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Hold | 1 | 3 | 1 | 5 |

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| May 14, 2026 | Citigroup | Maintained | Neutral | $44.00 |
| Apr 15, 2026 | Citigroup | Initiated Coverage | Neutral | $62.00 |
| Nov 7, 2025 | JP Morgan | Maintained | Overweight | $50.00 |
| Aug 29, 2025 | B of A Securities | Maintained | Underperform | $27.00 |
| Jul 7, 2025 | JP Morgan | Upgraded | Neutral → Overweight | $35.00 |
| Jun 25, 2025 | Morgan Stanley | Maintained | Equal-Weight | $26.00 |
| May 8, 2025 | Morgan Stanley | Maintained | Equal-Weight | $21.00 |
| Feb 10, 2025 | Barclays | Maintained | Underweight | $22.00 |
| Dec 17, 2024 | Morgan Stanley | Maintained | Equal-Weight | $25.00 |
| Nov 12, 2024 | Barclays | Maintained | Underweight | $20.00 |
| Sep 10, 2024 | JP Morgan | Initiated Coverage | Neutral | $22.00 |
| Aug 30, 2024 | B of A Securities | Maintained | Underperform | $15.00 |
| May 10, 2024 | Barclays | Maintained | Underweight | $13.00 |
| Nov 9, 2023 | Morgan Stanley | Maintained | Equal-Weight | $16.00 |
| Sep 1, 2023 | Roth MKM | Maintained | Buy | $21.00 |
| Aug 31, 2023 | Morgan Stanley | Maintained | Equal-Weight | $17.00 |
| Aug 29, 2023 | Roth MKM | Maintained | Buy | $21.00 |
| Jul 27, 2023 | Morgan Stanley | Maintained | Equal-Weight | $18.00 |
| May 4, 2023 | Morgan Stanley | Maintained | Equal-Weight | $18.00 |

## Frequently Asked Questions

### Is PAHC a buy, sell, or hold?

Analysts covering Phibro Animal Health currently average a Hold rating: 1 buy, 3 hold and 1 sell, from 5 analysts. Ratings reflect analyst opinion, not investment advice.

### What is the latest analyst rating on PAHC?

On May 14, 2026, Citigroup maintained Phibro Animal Health at Neutral with a price target of $44.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).